Affinity Investment Advisors’s Elevance Health ELV Stock Holding History

Affinity Investment Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-677	Closed	-$237K	–	140
2025 Q4	$237K	Sell	677 -628	-48%	-$212K	0.16%	130
2025 Q3	$422K	Buy	1,305 +44	+3%	+$13.7K	0.29%	90
2025 Q2	$490K	Sell	1,261 -3	-0.2%	-$1.21K	0.37%	83
2025 Q1	$550K	Buy	1,264 +207	+20%	+$83.1K	0.45%	81
2024 Q4	$390K	Sell	1,057 -113	-10%	-$47.3K	0.32%	95
2024 Q3	$608K	Hold	1,170	–	–	0.42%	82
2024 Q2	$634K	Buy	1,170 +123	+12%	+$65K	0.48%	75
2024 Q1	$543K	Sell	1,047 -7	-0.7%	-$3.48K	0.4%	84
2023 Q4	$497K	Buy	1,054 +404	+62%	+$187K	0.34%	86
2023 Q3	$283K	Sell	650 -4	-0.6%	-$1.81K	0.18%	162
2023 Q2	$291K	Buy	654 +2	+0.3%	+$923	0.17%	171
2023 Q1	$300K	Buy	652 +1	+0.2%	+$476	0.16%	163
2022 Q4	$334K	Sell	651 -120	-16%	-$60.9K	0.15%	160
2022 Q3	$350K	Hold	771	–	–	0.18%	161
2022 Q2	$372K	Sell	771 -744	-49%	-$368K	0.18%	161
2022 Q1	$744K	Sell	1,515 -39	-3%	-$17.8K	0.3%	125
2021 Q4	$720K	Buy	1,554 +133	+9%	+$56K	0.29%	125
2021 Q3	$530K	Buy	+1,421	New	+$540K	0.24%	135
2020 Q3	–	Sell	-899	Closed	-$236K	–	147
2020 Q2	$236K	Sell	899 -395	-31%	-$105K	0.11%	131
2020 Q1	$294K	Sell	1,294 -2,010	-61%	-$548K	0.15%	116
2019 Q4	$998K	Buy	3,304 +1,119	+51%	+$308K	0.36%	59
2019 Q3	$525K	Sell	2,185 -547	-20%	-$150K	0.16%	77
2019 Q2	$771K	Buy	2,732 +138	+5%	+$37.7K	0.22%	67
2019 Q1	$744K	Hold	2,594	–	–	0.15%	67
2018 Q4	$681K	Sell	2,594 -155	-6%	-$42.6K	0.12%	68
2018 Q3	$753K	Buy	2,749 +74	+3%	+$19.2K	0.1%	69
2018 Q2	$637K	Buy	2,675 +21	+0.8%	+$4.86K	0.09%	106
2018 Q1	$583K	Buy	2,654 +84	+3%	+$19.7K	0.07%	102
2017 Q4	$578K	Hold	2,570	–	–	0.07%	102
2017 Q3	$488K	Hold	2,570	–	–	0.06%	106
2017 Q2	$483K	Hold	2,570	–	–	0.06%	108
2017 Q1	$425K	Hold	2,570	–	–	0.04%	125
2016 Q4	$369K	Hold	2,570	–	–	0.03%	124
2016 Q3	$322K	Sell	2,570 -1,170	-31%	-$151K	0.03%	122
2016 Q2	$491K	Hold	3,740	–	–	0.04%	118
2016 Q1	$520K	Hold	3,740	–	–	0.05%	116
2015 Q4	$522K	Sell	3,740 -660	-15%	-$90.9K	0.04%	121
2015 Q3	$616K	Hold	4,400	–	–	0.06%	121
2015 Q2	$722K	Sell	4,400 -1,180	-21%	-$189K	0.06%	110
2015 Q1	$862K	Hold	5,580	–	–	0.06%	103
2014 Q4	$701K	Hold	5,580	–	–	0.06%	99
2014 Q3	$667K	Sell	5,580 -150	-3%	-$17.2K	0.07%	100
2014 Q2	$617K	Hold	5,730	–	–	0.07%	67
2014 Q1	$570K	Hold	5,730	–	–	0.07%	67
2013 Q4	$529K	Hold	5,730	–	–	0.06%	70
2013 Q3	$479K	Buy	5,730 +180	+3%	+$15.4K	0.06%	70
2013 Q2	$454K	Buy	+5,550	New	+$415K	0.04%	101

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Affinity Investment Advisors's ELV Position: Q1 2026 in Review

Affinity Investment Advisors sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 677 shares — an estimated $237K sold.

Affinity Investment Advisors first reported a position in ELV in Q2 2013 and held it in 47 quarters. The position peaked at $998K in Q4 2019. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Affinity Investment Advisors reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
Affinity Investment Advisors sold 677 Elevance Health shares in Q1 2026, an estimated $237K.
Affinity Investment Advisors first reported a position in Elevance Health in Q2 2013 and held it in 47 quarters.
Affinity Investment Advisors's Elevance Health position peaked at $998K in Q4 2019.
1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Affinity Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.